| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2014014794 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Abstract |
The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosteronemediated diseases. The invention furthermore relates to specific diastereomers and enantiomers of the compounds, to processes for preparing compounds of the Formula (I), to their potential use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula (I). |
| Applicant(s) |
Merck Sharp & Dohme Corp |
| Patent ID |
WO2013055608 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Abstract |
The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that are possible useful for treating aldosterone-mediated diseases. The invention furthermore relates to processes for preparing compounds of the Formula (I), to their possible use for the treatment of the above mentioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula (I). |
| Applicant(s) |
Merck Sharp & Dohme Corp |
| Patent ID |
WO2013055607 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Abstract |
The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that are aldosterone receptor antagonists which might be useful for treating aldosterone-mediated diseases. The invention furthermore relates to processes for preparing compounds of the Formula (I), to their possible use for the treatment of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula (I). |
| Applicant(s) |
Merck Sharp & Dohme Corp |
| Patent ID |
WO2013055606 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Abstract |
The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that are potentially useful for treating aldosterone-mediated diseases. The invention furthermore relates to processes for preparing compounds of the Formula (I), to their possible use in the treatment of the above mentioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula (I). |
| Applicant(s) |
Merck Sharp & Dohme Corp |
| Patent ID |
WO2012139495 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Abstract |
Compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosterone-mediated diseases are disclosed. Processes for preparing compounds of the Formula (I), use of the compounds for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and pharmaceutical compositions which comprise compounds of the Formula (I) are disclosed. |
| Applicant(s) |
Merck Sharp & Dohme Corp |
| United States Patent and Trademark Office (USPTO) |
| Patent ID |
US20150284376 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Applicant(s) |
Merck Sharp & Dohme Corp |
| Representative Drug(s) |
D01VJR |
Drug Info
|
N.A. |
Click to Show More |
[1] |
|
2
|
D02LAD
|
Drug Info
|
N.A.
|
[1] |
|
3
|
D08NNH
|
Drug Info
|
N.A.
|
[1] |
|
4
|
D0LZ4V
|
Drug Info
|
N.A.
|
[1] |
|
5
|
D0NC3Q
|
Drug Info
|
N.A.
|
[1] |
| Patent ID |
US8933113 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Applicant(s) |
Merck Sharp & Dohme |
| European Patent Office (EPO) |
| Patent ID |
EP2665707 |
| Title |
Mineralocorticoid Receptor Antagonists. |
| Applicant(s) |
Merck Sharp & Dohme |
| Representative Drug(s) |
D02LAD |
Drug Info
|
N.A. |
[1] |
